Ausgabe 3/2019
Inhalt (27 Artikel)
Treatment of aggressive recurrent meningiomas: spinning towards peptide receptor radionuclide therapy
Eric Guedj, Thomas Graillon, Olivier Chinot, David Taieb
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law, Nathalie L. Albert, Javier Arbizu, Ronald Boellaard, Alexander Drzezga, Norbert Galldiks, Christian la Fougère, Karl-Josef Langen, Egesta Lopci, Val Lowe, Jonathan McConathy, Harald H. Quick, Bernhard Sattler, David M. Schuster, Jörg-Christian Tonn, Michael Weller
18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
Olivier Humbert, Véronique Bourg, Lydiane Mondot, Jocelyn Gal, Pierre-Yves Bondiau, Denys Fontaine, Esma Saada-Bouzid, Marie Paquet, David Chardin, Fabien Almairac, Fanny Vandenbos, Jacques Darcourt
Region-by-region analysis of PET, MRI, and histology in en bloc-resected oligodendrogliomas reveals intra-tumoral heterogeneity
Kenney Roy Roodakker, Ali Alhuseinalkhudhur, Mohammed Al-Jaff, Maria Georganaki, Maria Zetterling, Shala G. Berntsson, Torsten Danfors, Robin Strand, Per-Henrik Edqvist, Anna Dimberg, Elna-Marie Larsson, Anja Smits
Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study
Marcus Unterrainer, D. F. Fleischmann, C. Diekmann, L. Vomacka, S. Lindner, F. Vettermann, M. Brendel, V. Wenter, B. Ertl-Wagner, J. Herms, C. Wetzel, R. Rupprecht, J. C. Tonn, C. Belka, P. Bartenstein, M. Niyazi, Nathalie L. Albert
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
Philipp Lohmann, Pantelis Stavrinou, Katharina Lipke, Elena K. Bauer, Garry Ceccon, Jan-Michael Werner, Bernd Neumaier, Gereon R. Fink, Nadim J. Shah, Karl-Josef Langen, Norbert Galldiks
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma
Michael Lundemann, Per Munck af Rosenschöld, Aida Muhic, Vibeke A. Larsen, Hans S. Poulsen, Svend-Aage Engelholm, Flemming L. Andersen, Andreas Kjær, Henrik B. W. Larsson, Ian Law, Adam E. Hansen
Safety and efficacy of targeted alpha therapy with 213Bi-DOTA-substance P in recurrent glioblastoma
Leszek Królicki, Frank Bruchertseifer, Jolanta Kunikowska, Henryk Koziara, Bartosz Królicki, Maciej Jakuciński, Dariusz Pawlak, Christos Apostolidis, Saed Mirzadeh, Rafał Rola, Adrian Merlo, Alfred Morgenstern
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma
Francesco Giammarile, Clare Schilling, Gopinanth Gnanasegaran, Chandrasckhar Bal, Wim J. G. Oyen, Domenico Rubello, Thomas Schwarz, Girolamo Tartaglione, Rodolfo Nuñez Miller, Diana Paez, Fijis W. B. van Leeuwen, Renato A. Valdés Olmos, Mark McGurk, Roberto C. Delgado Bolton
PET-based prognostic survival model after radiotherapy for head and neck cancer
Joël Castelli, A. Depeursinge, A. Devillers, B. Campillo-Gimenez, Y. Dicente, J. O. Prior, E. Chajon, F. Jegoux, C. Sire, O. Acosta, E. Gherga, X. Sun, B. De Bari, J. Bourhis, R. de Crevoisier
Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma
Yu-Hung Chen, Kai-Ping Chang, Sung-Chao Chu, Tzu-Chen Yen, Ling-Yi Wang, Joseph Tung-Chieh Chang, Cheng-Lung Hsu, Shu-Hang Ng, Shu-Hsin Liu, Sheng-Chieh Chan
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
Alberta Cappelli, Paloma Sangro, Cristina Mosconi, Iris Deppe, Eleonora Terzi, Jose I. Bilbao, Macarena Rodriguez-Fraile, Caterina De Benedittis, Jens Ricke, Rita Golfieri, Bruno Sangro
Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience
Héloïse Bourien, Xavier Palard, Yan Rolland, Fanny Le Du, Luc Beuzit, Thomas Uguen, Samuel Le Sourd, Marc Pracht, Vincent Manceau, Astrid Lièvre, Karim Boudjema, Etienne Garin, Julien Edeline
Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
Simone Krebs, Neeta Pandit-Taskar, Diane Reidy, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang A. Weber, Joseph A. O’Donoghue
Early 18F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma
Benjamin Leroy-Freschini, Vincent Amodru, Pietro Addeo, Frédéric Sebag, Michel Vix, Laurent Brunaud, Marc Klein, Thibault Bahougne, Philippe Bachellier, Frédéric Castinetti, Bernard Goichot, Elodie Chevalier, David Taieb, Alessio Imperiale
Influence of lanreotide on uptake of 68Ga-DOTATATE in patients with neuroendocrine tumours: a prospective intra-patient evaluation
E. A. Aalbersberg, B. J. de Wit – van der Veen, M. W. J. Versleijen, L. J. Saveur, G. D. Valk, M. E. T. Tesselaar, M. P. M. Stokkel
Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
W. A. van der Zwan, T. Brabander, B. L. R. Kam, J. J. M. Teunissen, R. A. Feelders, J. Hofland, E. P. Krenning, W. W. de Herder
Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
Grace Kong, Simona Grozinsky-Glasberg, Michael S. Hofman, Tim Akhurst, Amichay Meirovitz, Ofra Maimon, Yodphat Krausz, Jeremy Godefroy, Michael Michael, David J. Gross, Rodney J. Hicks
Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
Michela Del Prete, François-Alexandre Buteau, Frédéric Arsenault, Nassim Saighi, Louis-Olivier Bouchard, Alexis Beaulieu, Jean-Mathieu Beauregard
Regulation of human brown adipose tissue by adenosine and A2A receptors – studies with [15O]H2O and [11C]TMSX PET/CT
Minna Lahesmaa, Vesa Oikonen, Semi Helin, Pauliina Luoto, Mueez U Din, Alexander Pfeifer, Pirjo Nuutila, Kirsi A. Virtanen
Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis
Giorgio Treglia, Arnoldo Piccardo, Alessio Imperiale, Klaus Strobel, Philipp A. Kaufmann, John O. Prior, Luca Giovanella
Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile
Arnoldo Piccardo, P. Trimboli, M. Rutigliani, M. Puntoni, L. Foppiani, L. Bacigalupo, Anna Crescenzi, G. Bottoni, G. Treglia, F. Paparo, P. Del Monte, M. Lanata, G. Paone, G. Ferrarazzo, U. Catrambone, A. Arlandini, L. Ceriani, M. Cabria, L. Giovanella
Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI
Christian Philipp Reinert, Martin Ulrich Schuhmann, Benjamin Bender, Isabel Gugel, Christian la Fougère, Jürgen Schäfer, Sergios Gatidis
Ectopic corticotropin-releasing hormone syndrome caused by pancreatic neuroendocrine tumor localized by 68Ga-DOTATATE PET/CT
Guozhu Hou, Yuanyuan Jiang, Wuying Cheng